SEC Form 4 · accession 0001179110-18-000645
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Miles D White
Officer — Chairman and CEO · Director
Period of report
Dec 22, 2017
Accepted (ET)
Jan 5, 2018 · 5:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Dec 22, 2017 | G | 440 | $0.00 | D | 3,086,445 | D | |
| Common shares without par valueF1 | holding | — | — | — | 31,675 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 9,978 | I | By son | |
| Common shares without par valueF2 | holding | — | — | — | 9,992 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of January 3, 2018.
- F2The reporting person disclaims beneficial ownership of all securities held by his son.